CohBar (NASDAQ:CWBR) Stock Price Up 12.5%

CohBar, Inc. (NASDAQ:CWBR) shares rose 12.5% on Wednesday . The company traded as high as $0.90 and last traded at $0.90. Approximately 356 shares traded hands during mid-day trading, a decline of 89% from the average daily volume of 3,366 shares. The stock had previously closed at $0.80.

CohBar Price Performance

The business’s 50 day moving average is $0.82 and its two-hundred day moving average is $1.08. The firm has a market capitalization of $2.62 million, a PE ratio of -0.21 and a beta of 1.54.

Institutional Inflows and Outflows

Several large investors have recently made changes to their positions in the business. RVW Wealth LLC bought a new position in shares of CohBar in the fourth quarter worth approximately $4,029,000. Millennium Management LLC grew its holdings in shares of CohBar by 241.1% in the second quarter. Millennium Management LLC now owns 208,603 shares of the company’s stock worth $40,000 after purchasing an additional 147,442 shares during the last quarter. Finally, Vanguard Group Inc. grew its holdings in shares of CohBar by 88.5% in the third quarter. Vanguard Group Inc. now owns 33,293 shares of the company’s stock worth $103,000 after purchasing an additional 15,628 shares during the last quarter. 2.47% of the stock is owned by hedge funds and other institutional investors.

CohBar Company Profile

CohBar, Inc, a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases.